Home›People›Deepak Sampath
Deepak Sampath

Deepak Sampath

Independent Director at BioGene Therapeutics.

Director
Updated Nov 9, 2026·Latest SEC filing Aug 7, 2026·Suggest an edit

About Deepak Sampath

Deepak Sampath is an independent director at BioGene Therapeutics.

Experience

This experience comes from Deepak Sampath's profile and from SEC filings. For roles taken from filings, the years are when the filings name Deepak Sampath in the role, so the role may have started earlier or lasted longer.

BioGene Therapeutics Inc. Current
Independent Director
Member Board of Directors (2024 – Present)
2024 – Present · Austin, TX
Develops gene therapies for people with diabetes and obesity.
Ultragenyx Pharmaceutical Inc.
Senior Vice President, Head of Research
2018 – 2026
Keystone Symposia on Molecular & Cellular Biology
Scientific Advisory Board Member
2019 – 2025
Nabla Bio
Scientific Advisory Board Member
2021 – 2022
Genentech
Principal Scientist
2006 – 2018
Pfizer
Principal Research Scientist
2001 – 2006

Key Colleagues at Startups

The people Deepak Sampath works with at each company, as listed on that company's latest Form D.

BioGene Therapeutics Inc. · Form D, Aug 7, 2026
Steve Glover
Steve Glover
Board Member
DH
David Howton
Director
Stephen Van Deventer
Stephen Van Deventer
Chief Executive Officer & President, director
Raj Pruthi
Raj Pruthi
Independent Director
Patroski Lawson
Patroski Lawson
Independent Director

Sources

  1. SECBioGene Therapeutics Inc. Form D, filed Aug 7, 2026